MyChesCo on MSN42m
Annovis Bio to Showcase Advancements at Alzheimer’s & Parkinson’s Drug Development SummitMALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is set to participate in the 13th Alzheimer’s & Parkinson’s Drug Development ...
Money Talks News on MSN21h
2 Types of Body Fat Are Now Linked to Dementia, Parkinson’s RiskCarrying excess fat in your arms and belly might put you at higher risk for Alzheimer’s disease and Parkinson’s disease, ...
Irish Mirror on MSN1d
Parkinson's disease: Early symptoms you may not recognise, including little-known nose issueParkinson's disease affects around 18,000 people in Ireland and can present with over 40 symptoms. While typically diagnosed ...
Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.
2024 — The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, ...
Researchers at McGill University found that a blood test originally designed for Alzheimer’s can predict dementia risk in ...
Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...
Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.
The 13th Alzheimer’s & Parkinson’s Drug Development Summit is the only industry-focused, end-to-end meeting that provides comprehensive coverage from early discovery to late-stage development focused ...
A Dominion Hills woman diagnosed with early-onset Parkinson's disease received national recognition last month for her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback